Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of CAR T-Cell Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CAR T-Cell Immunotherapymarket, defines the market attractiveness level of CAR T-Cell Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CAR T-Cell Immunotherapy industry, describes the types of CAR T-Cell Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global CAR T-Cell Immunotherapy market and the development prospects and opportunities of CAR T-Cell Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CAR T-Cell Immunotherapy market in Chapter 13.
By Player:
CARsgen Therapeutics
Celgene
Kite Pharma
Xyphos
Bellicum
Mustang Bio
AbbVie
Oxford BioMedica
Minerva Biotechnologies
Aurora Biopharma
Ziopharm Oncology
Adaptimmune
Gilead
Pfizer
Creative Biolabs
Cellectis
Novartis
By Type:
Monotherapy
Combination Therapy
By End-User:
Hematologic Malignancies
Solid Malignancies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CAR T-Cell Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CAR T-Cell Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CAR T-Cell Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CAR T-Cell Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CAR T-Cell Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.2 United States CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.3 Europe CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.4 China CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.5 Japan CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.6 India CAR T-Cell Immunotherapy Consumption (2017-2022)
-
7.7 South Korea CAR T-Cell Immunotherapy Consumption (2017-2022)
8 Region and Country-wise CAR T-Cell Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea CAR T-Cell Immunotherapy Consumption Forecast (2022-2028)
9 Global CAR T-Cell Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global CAR T-Cell Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global CAR T-Cell Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Solid Malignancies Consumption and Growth Rate (2017-2022)
10 Global CAR T-Cell Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Solid Malignancies Consumption Forecast and Growth Rate (2022-2028)
11 Global CAR T-Cell Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global CAR T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CAR T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CAR T-Cell Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CAR T-Cell Immunotherapy Market Competitive Analysis
-
14.1 CARsgen Therapeutics
-
14.1.1 CARsgen Therapeutics Company Details
-
14.1.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Product and Service
-
14.2 Celgene
-
14.2.1 Celgene Company Details
-
14.2.2 Celgene CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celgene CAR T-Cell Immunotherapy Product and Service
-
14.3 Kite Pharma
-
14.3.1 Kite Pharma Company Details
-
14.3.2 Kite Pharma CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Kite Pharma CAR T-Cell Immunotherapy Product and Service
-
14.4 Xyphos
-
14.4.1 Xyphos Company Details
-
14.4.2 Xyphos CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Xyphos CAR T-Cell Immunotherapy Product and Service
-
14.5 Bellicum
-
14.5.1 Bellicum Company Details
-
14.5.2 Bellicum CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bellicum CAR T-Cell Immunotherapy Product and Service
-
14.6 Mustang Bio
-
14.6.1 Mustang Bio Company Details
-
14.6.2 Mustang Bio CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mustang Bio CAR T-Cell Immunotherapy Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie CAR T-Cell Immunotherapy Product and Service
-
14.8 Oxford BioMedica
-
14.8.1 Oxford BioMedica Company Details
-
14.8.2 Oxford BioMedica CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Oxford BioMedica CAR T-Cell Immunotherapy Product and Service
-
14.9 Minerva Biotechnologies
-
14.9.1 Minerva Biotechnologies Company Details
-
14.9.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Product and Service
-
14.10 Aurora Biopharma
-
14.10.1 Aurora Biopharma Company Details
-
14.10.2 Aurora Biopharma CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Aurora Biopharma CAR T-Cell Immunotherapy Product and Service
-
14.11 Ziopharm Oncology
-
14.11.1 Ziopharm Oncology Company Details
-
14.11.2 Ziopharm Oncology CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Ziopharm Oncology CAR T-Cell Immunotherapy Product and Service
-
14.12 Adaptimmune
-
14.12.1 Adaptimmune Company Details
-
14.12.2 Adaptimmune CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Adaptimmune CAR T-Cell Immunotherapy Product and Service
-
14.13 Gilead
-
14.13.1 Gilead Company Details
-
14.13.2 Gilead CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Gilead CAR T-Cell Immunotherapy Product and Service
-
14.14 Pfizer
-
14.14.1 Pfizer Company Details
-
14.14.2 Pfizer CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Pfizer CAR T-Cell Immunotherapy Product and Service
-
14.15 Creative Biolabs
-
14.15.1 Creative Biolabs Company Details
-
14.15.2 Creative Biolabs CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Creative Biolabs CAR T-Cell Immunotherapy Product and Service
-
14.16 Cellectis
-
14.16.1 Cellectis Company Details
-
14.16.2 Cellectis CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Cellectis CAR T-Cell Immunotherapy Product and Service
-
14.17 Novartis
-
14.17.1 Novartis Company Details
-
14.17.2 Novartis CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Novartis CAR T-Cell Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CAR T-Cell Immunotherapy
-
Figure CAR T-Cell Immunotherapy Picture
-
Table Global CAR T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CAR T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CAR T-Cell Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CAR T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure United States CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea CAR T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global CAR T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CAR T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hematologic Malignancies Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Malignancies Consumption and Growth Rate (2017-2022)
-
Figure Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematologic Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Malignancies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CAR T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CAR T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table CARsgen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene CAR T-Cell Immunotherapy Product and Service
-
Table Kite Pharma (Foundation Year, Company Profile and etc.)
-
Table Kite Pharma CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma CAR T-Cell Immunotherapy Product and Service
-
Table Xyphos (Foundation Year, Company Profile and etc.)
-
Table Xyphos CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xyphos CAR T-Cell Immunotherapy Product and Service
-
Table Bellicum (Foundation Year, Company Profile and etc.)
-
Table Bellicum CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bellicum CAR T-Cell Immunotherapy Product and Service
-
Table Mustang Bio (Foundation Year, Company Profile and etc.)
-
Table Mustang Bio CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mustang Bio CAR T-Cell Immunotherapy Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie CAR T-Cell Immunotherapy Product and Service
-
Table Oxford BioMedica (Foundation Year, Company Profile and etc.)
-
Table Oxford BioMedica CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford BioMedica CAR T-Cell Immunotherapy Product and Service
-
Table Minerva Biotechnologies (Foundation Year, Company Profile and etc.)
-
Table Minerva Biotechnologies CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Minerva Biotechnologies CAR T-Cell Immunotherapy Product and Service
-
Table Aurora Biopharma (Foundation Year, Company Profile and etc.)
-
Table Aurora Biopharma CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurora Biopharma CAR T-Cell Immunotherapy Product and Service
-
Table Ziopharm Oncology (Foundation Year, Company Profile and etc.)
-
Table Ziopharm Oncology CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ziopharm Oncology CAR T-Cell Immunotherapy Product and Service
-
Table Adaptimmune (Foundation Year, Company Profile and etc.)
-
Table Adaptimmune CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adaptimmune CAR T-Cell Immunotherapy Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead CAR T-Cell Immunotherapy Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer CAR T-Cell Immunotherapy Product and Service
-
Table Creative Biolabs (Foundation Year, Company Profile and etc.)
-
Table Creative Biolabs CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Creative Biolabs CAR T-Cell Immunotherapy Product and Service
-
Table Cellectis (Foundation Year, Company Profile and etc.)
-
Table Cellectis CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis CAR T-Cell Immunotherapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis CAR T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis CAR T-Cell Immunotherapy Product and Service
-
